FAQ

Fragmin

Known as: Fragmine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2016
0102019802016

Related topics

Related topics

4 relations

Broader (4)

Actin-Binding ProteinDalteparinDalteparin SodiumHeparin, Low-Molecular-Weight

Related mentions per year

Related mentions per year

1961-2018
1960198020002020
Fragmin
Heparin, Low-Molecular-Weight
Dalteparin
Actin-Binding Protein
Dalteparin Sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).
PURPOSE In experimental systems, interference with coagulation can affect tumor biology. Furthermore, it has been suggested that… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
BACKGROUND In patients with unstable coronary artery disease, there is a relation between the short-term risk of death and blood… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group.
OBJECTIVES We sought to evaluate whether troponin T might be used for identification of patients with unstable coronary artery… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
BACKGROUND The prognostic influences of fibrinogen and C-reactive protein levels and their relations to myocardial damage in… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery…
BACKGROUND Low-molecular-weight heparin has a number of pharmacological and pharmacokinetic advantages over unfractionated… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Upper extremity deep venous thrombosis in cancer patients with venous access devices--prophylaxis with a low molecular weight heparin (Fragmin).
Central venous access devices are often essential for the administration of chemotherapy to patients with malignancy, but its use… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.
Two hundred and four consecutive patients with venographically confirmed deep vein thrombosis (DVT) were randomised either to a… (More)
Is this relevant?
1987
1987
Pharmacokinetics of heparin and low molecular weight heparin fragment (Fragmin) in rabbits with impaired renal or metabolic clearance.
The kinetics and tissue distribution of 3H-heparin and a 3H-labelled low molecular weight heparin fragment were compared in… (More)
Is this relevant?
1986
1986
Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers.
The pharmacokinetics of a low molecular weight heparin (LMWH) with a mean mw of 4000-6000 D (KABI 2165, Fragmin) was studied in 6… (More)
Is this relevant?
Highly Cited
1980
Highly Cited
1980
Fragmin: a calcium ion sensitive regulatory factor on the formation of actin filaments.
Physarum actinin previously isolated [Hatano, S., & Owaribe, K. (1976) in Cell Motility (Goldman, R., Pollard, T., & Rosenbaum, J… (More)
Is this relevant?